Log in

News

Watch Controversies in Gastroesophageal Reflux Disease (GERD)

18 Dec 2020 3:04 PM | Anonymous

Gastroesophageal Reflux Disease (GERD) is the most prevalent esophageal disease. It is a condition affecting up to 20% of the western world and has a significant negative impact in the patient’s quality of life. The typical symptoms are heartburn and regurgitation, but other clinical presentations can be present.

The Controversies in Gastroesophageal Reflux Disease virtual presentation was held on December 16, 2020. Moderated by Jan Tack, University of Leuven (The Netherlands) and Kerry Dunbar, University of Texas Southwestern Medical Center (USA) the 90 minute presentation is available in three segments below. What different segments when you have time or all at once, the choice is yours.

Part 1 | Long term PPI therapy with Kerry Dunbar


Part 2 | Endoscopic management of GERD with Haruhiro Inoue


Part 3 | When to consider surgery with John Lipham

ISDE wishes to recognize and thank the following individuals for their contributions to this virtual presentation:

  • Jan Tack, University of Leuven (The Netherlands)
  • Kerry Dunbar, University of Texas Southwestern Medical Center (USA) (moderator and speaker)
  • Haruhiro Inoue, Showa University School of Medicine (Japan)
  • John Lipham, Keck School of Medicine of USC (USA)

Want to know more?

WATCH Interviews and Discussions in the GERD Playlist

Search Diseases of the Esophagus Journal for articles on Gastroesophageal Reflux Disease. There are 55 Free articles available.

Join the discussion in the ISDE Challenging Cases Facebook Group


Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software